Beta blockade during and after myocardial infarction: An overview of the randomized trials
References (157)
Clinical experience with beta-adrenergic blocking agents in myocardial ischameia: a dilemma and a challenge
Pharmacol Ther
(1981)- et al.
Effect of hypoxemia on the extent of myocardial necrosis after experimental coronary occlusion
Am J Cardiol
(1975) - et al.
Prolonged protective effect of propranolol on hypoxic heart muscle
Am J Cardiol
(1978) - et al.
Changes in infarct size following administration of propranolol in the conscious dog
Am J Cardiol
(1973) - et al.
On the nature of protection by propranolol against myocardial necrosis after temporary coronary occlusion in dogs
Am J Cardiol
(1976) Treatment of acute myocardial infarction with propranolol
Am J Cardiol
(1966)- et al.
A controlled trial of propranolol in acute myocardial infarction
Lancet
(1966) - et al.
Absence of prophylactic effect of propranolol in myocardial infarction
Lancet
(1966) - et al.
Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction
Lancet
(1980) - et al.
Effect of atenolol on recovery of the electrocardiographic signs of myocardial infarction
Lancet
(1979)
Protective effect of propranolol in threatened myocardial infarction
Lancet
(1978)
Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propanolol
Lancet
(1984)
Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction: Preminary results
Lancet
(1979)
Effect on mortality of metoprolol in acute myocardial infarction: A double-blind randomised trial
Lancet
(1981)
Limitation of infaret size in acute myocardial infarction with metoprolol
Am J Cardiol
(1982)
Natural history of acute coronary heart attacks: A community study
Br Heart J
(1972)
Incidence and presentation of myocardial infarction in an English community
Br Heart J
(1973)
Coronary heart attacks in East London
Lancet
(1975)
Estimation of infarct size in man and its relation to prognosis
Circulation
(1972)
Relation of cardiac complications to SGOT level in acute myocardial infarction
Br Heart J
(1972)
Enzymatic indices of myocardial necrosis: Influence of short-and longterm prognosis after myocardial infarction
Circulation
(1979)
Myocardial changes associated with cardiogenic shock
Engl J Med
(1971)
Infarct size estimated from serial serum creatine phosphokinase in relation to left ventricular hemodynamics
Circulation
(1977)
Treatment of acute myocardial infarction with propranolol: Further studies on enzyme appearance and subsequent left ventricular function in treated and control patients with developing infarcts
Br Heart J
(1980)
Factors influencing infarct size following experimental coronary occlusions
Circulation
(1971)
Effects of coronary perfusion during myocardial hypoxia: Comparison of metabolic and hemodynamic events with global ischemia and hypoxemia
J Thorac Cardiovasc Surg
(1976)
Effect of acute anemia on experimental myocardial ischemia
Am J Cardiol
(1973)
The effect of hypoglycemia on myocardial ischemic injury during acute experimental coronary artery occlusion
Circulation
(1975)
Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction
J Clin Invest
(1974)
Effect of reducing circulating free fatty acids on ventricular arrhythmias during myocardial infarction and on ST-segment depression during exercise-induced ischemia
Circulation
(1976)
Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs
J Clin Invest
(1971)
Propranolol in the treatment of acute myocardial infarction; effect on myocardial oxygenation and hemodynamics
Circulation
(1974)
Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart
J Clin Invest
(1972)
Isoproterenol-induced “coronary steal”: Metabolic observations in human coronary heart disease
Clin Res
(1969)
Effect of isoproterenol on collateral blood flow in ischemic myocardium
Clin Res
(1973)
Regional ischemic ventricular dysfunction in myocardium supplied by a narrowed coronary artery with increasing halothane concentration in the dog
Anesthesiology
(1981)
Determinants of prognosis in survivors of myocardial infarction
N Engl J Med
(1982)
Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man
J Clin Invest
(1980)
Clinical investigation of techniques to protect ischemic myocardium and minimize infarct size. Final Report
Contract NO1-HV-62960-1 from the National Heart, Lung and Blood Institute
(1981)
Effect of propranolol on regional myocardial blood flow in acute ischemia
Cardiovasc Res
(1970)
Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle
Circ Res
(1971)
Effects of gropranolol on regional myocardial function, electrocardiograms, and blood flow in conscious dogs with myocardial ischemia
J Clin Invest
(1977)
Myocardial enzyme release from ischemic isolated perfused working rat heart
A possible role of noradrenaline in the development of myocardial infarction: An experimental study in the isolated rat heart
Am Heart J
(1979)
Propranolol and experimental myocardial infarction: Substrate effects
Postgrad Med J
(1976)
The effect of propranolol on microvascular injury in acute myocardial ischemia
Circulation
(1977)
Effect of practolol on the extent of myocardial ischaemic injury after experimental coronary occlusion and its effects on ventricular function in normal and ischaemic heart
Cardiovasc Res
(1973)
The effect of delay in propranolol administration on reduction of myocardial infarct size after experimental coronary artery occlusion in dogs
Circulation
(1979)
Statistical aspects of the analysis of data from retrospective studies of disease
J Natl Cancer Inst
(1959)
Propranolol in acute myocardial infarction
Lancet
(1966)
Cited by (0)
- 1
From the Clinical Trial Service Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford, UK; the Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK; and Imperial Chemical Industries PLC, Pharmaceuticals Division, Macclesfield, Cheshire, UK.
Copyright © 1985 Published by Elsevier Inc.